FDA Notices of Judgment Collection, 1908-1966

3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust.

Case Number:
3921
Collection:
Drugs and Devices, 1940-1963
Evidence Numbers:
F. D. C. No. 33712. Sample Nos. 4 17021-L, 17048-L, 17325-L, 17563-L, 17567-L.
Date Issued:
August 1953
Seizure Dates:
May 4, 7, 9, and 11, 1951, and April 22, 1952
Product Keywords:
methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium capsules
Defendant Names:
Andrew J. Kennedy, trading as Kennedy Drugs, Los Angeles, Calif., and Paul J. Argust, a pharmacist employed by Mr. Kennedy.
Court Jurisdiction:
Southern District of California
Seizure Location:
Los Angeles, Calif.
Shipped From:
Los Angeles, Calif.
Shipped To:
Los Angeles, Calif.
Copyright:
The National Library of Medicine believes this item to be in the public domain (More information)